Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma

Author:

Carvajal Richard D.1,Sosman Jeffrey A.2,Quevedo Jorge Fernando3,Milhem Mohammed M.4,Joshua Anthony M.5,Kudchadkar Ragini R.6,Linette Gerald P.7,Gajewski Thomas F.8,Lutzky Jose9,Lawson David H.10,Lao Christopher D.11,Flynn Patrick J.12,Albertini Mark R.13,Sato Takami14,Lewis Karl15,Doyle Austin16,Ancell Kristin2,Panageas Katherine S.17,Bluth Mark17,Hedvat Cyrus17,Erinjeri Joseph17,Ambrosini Grazia17,Marr Brian17,Abramson David H.1,Dickson Mark Andrew1,Wolchok Jedd D.1,Chapman Paul B.1,Schwartz Gary K.1

Affiliation:

1. Memorial Sloan-Kettering Cancer Center, New York, New York2Weill Medical College of Cornell University, New York, New York

2. Vanderbilt University Medical Center, Department of Hematology-Oncology, Nashville, Tennessee

3. Mayo Clinic, Rochester, Minnesota

4. University of Iowa Hospital and Clinics, Iowa City

5. Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada

6. H. Lee Moffitt Cancer Center, Tampa, Florida

7. Washington University, St Louis, Missouri

8. University of Chicago, Chicago, Illinois

9. Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida

10. Winship Cancer Institute of Emory University, Atlanta, Georgia

11. University of Michigan, Ann Arbor

12. Metro Minnesota Community Clinical Oncology Program, St Louis Park

13. University of Wisconsin, Madison

14. Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania

15. University of Colorado, Aurora

16. Investigational Drug Branch, National Cancer Institute, Rockville, Maryland

17. Memorial Sloan-Kettering Cancer Center, New York, New York

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 376 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Ocular complications in patients undergoing initial chemotherapy;Gazzetta Medica Italiana Archivio per le Scienze Mediche;2024-09

2. Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literature;Supportive Care in Cancer;2024-08-23

3. Personalized treatment approaches in intraocular cancer;Advances in Ophthalmology Practice and Research;2024-08

4. Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis;Human Vaccines & Immunotherapeutics;2024-07-14

5. BET Bromodomain Inhibition Potentiates Ocular Melanoma Therapy by Inducing Cell Cycle Arrest;Investigative Ophthalmology & Visual Science;2024-07-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3